PepO treatment dramatically increased tumor infiltrating macrophages (F4/80+) and iNOS+ M1 macrophages while decreasing Arg-1+ M2 macrophages in TME (Fig. 3D and Additional file 1: Fig S3A). The gene discussed is ARG1; the disease is neoplasm.